Publisher: Elsevier

Related content
Volume 2, Number 3, 1 June 2002

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Pharmacology
pp. 195-206(12)
Authors: Khakh, B.; Dickenson, T.; Flavahan, N.; Chatterjee, P.; Thiemermann, C.; Newton, R.; Lindsay, M.; Rowan, D.; Bigg, H.; Futscher, B.; William, P.; Brady, G.; Sharkey, K.; van Sickle, M.; Furman, B.

Favourites:Add to Favourites

Respiratory: Musculoskeletal
pp. 207-207(1)
Author: Carpenter, K.J.

Favourites:Add to Favourites

Respiratory pharmacology of airway nerves
pp. 209-210(2)
Authors: Page, C.P.; Spina, D.

Favourites:Add to Favourites

Overview of the innervation of the lung
pp. 211-215(5)
Author: Belvisi, M.G.

Favourites:Add to Favourites

The study of airway primary afferent neuron excitability
pp. 216-219(4)
Authors: Carr, M.J.; Ellis, J.L.

Favourites:Add to Favourites

Central nervous system control of the airways: pharmacological implications
pp. 220-228(9)
Authors: Mazzone, S.B.; Canning, B.J.

Favourites:Add to Favourites

Control of nerve growth and plasticity
pp. 229-234(6)
Authors: Braun, A.; Nockher, W.A.; Renz, H.

Favourites:Add to Favourites

Hot channels in airways: pharmacology of the vanilloid receptor
pp. 235-242(8)
Authors: Hwang, S.W.; Oh, U.

Favourites:Add to Favourites

Interactions between inflammatory cells and nerves
pp. 243-248(6)
Authors: Curran, D.R.; Walsh, M.T.; Costello, R.W.

Favourites:Add to Favourites

Neuroregulation of cough: implications for drug therapy
pp. 256-263(8)
Author: Widdicombe, J.

Favourites:Add to Favourites

Pharmacology of airway irritability
pp. 264-272(9)
Authors: Spina, D.; Page, C.P.

Favourites:Add to Favourites

Airway nerves: detection and visualisation
pp. 273-277(5)
Authors: Goldie, R.G.; Fernandes, L.; Rigby, P.

Favourites:Add to Favourites

Airway nerves: in vitro electrophysiology
pp. 278-279(2)
Author: Fox, A.

Favourites:Add to Favourites

Airway nerves: in vivo electrophysiology
pp. 280-282(3)
Author: Adcock, J.J.

Favourites:Add to Favourites

Airway nerves: neurotransmitter release
pp. 283-285(3)
Author: Spina, D.

Favourites:Add to Favourites

Musculoskeletal diseases: novel targets for therapeutic intervention
pp. 287-290(4)
Authors: Lark, M.W.; Morrison, K.E.

Favourites:Add to Favourites

Immunosuppression in peripheral neuropathy: rationale and reality
pp. 291-295(5)
Authors: Sutton, I.J.; Winer, J.B.

Favourites:Add to Favourites

Diseases of the neuromuscular junction
pp. 296-301(6)
Authors: McConville, J.; Vincent, A.

Favourites:Add to Favourites

Therapies in amyotrophic lateral sclerosis-beyond riluzole
pp. 302-309(8)
Author: Morrison, K.E.

Favourites:Add to Favourites

Chronic pain: mechanisms and treatment
pp. 310-315(6)
Authors: Priest, T.D.; Hoggart, B.

Favourites:Add to Favourites

Small-molecule inhibitors of NF-B for the treatment of inflammatory joint disease
pp. 316-321(6)
Authors: Roshak, A.K.; Callahan, J.F.; Blake, S.M.

Favourites:Add to Favourites

Aggrecanase-mediated cartilage degradation
pp. 322-329(8)
Author: Arner, E.C.

Favourites:Add to Favourites

Novel bone antiresorptive approaches
pp. 330-337(8)
Authors: Lark, M.W.; James, I.E.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more